Related Experiment Video
Updated: Feb 10, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Tight glycemic control in critically ill pediatric patients: a meta-analysis and systematic review of randomized
Yiyang Zhao1, Yang Wu1, Bo Xiang2
1Department of Pediatric Surgery, Sichuan University West China Hospital, Chengdu, Sichuan, People's Republic of China.
Insights
Tight glycemic control (TGC) in critically ill children does not lower mortality or infection rates. However, TGC significantly increases the risk of hypoglycemia, a serious complication requiring careful consideration in pediatric intensive care units (PICUs).
Area of Science:
- Pediatric Critical Care Medicine
- Endocrinology
- Clinical Research Methodology
Background:
- Controversies exist regarding the impact of tight glycemic control (TGC) in critically ill children.
- Pediatric intensive care units (PICUs) face challenges in optimizing glucose management for critically ill youth.
Purpose of the Study:
- To assess the benefits and risks of tight glycemic control (TGC) versus conventional glycemic control (CGC).
- To evaluate TGC's effect on mortality, infections, and hypoglycemia in critically ill children using randomized controlled trial (RCT) data.
Main Methods:
- A meta-analysis was conducted using data from five randomized controlled trials (RCTs).
- Searched databases included EMBASE, CNKI, PubMed, and the Cochrane Database for relevant RCTs.
- Included 3933 critically ill pediatric patients admitted to the PICU.
Main Results:
- Tight glycemic control (TGC) did not significantly reduce 30-day mortality rates compared to conventional glycemic control (CGC).
- TGC was not associated with a decrease in health care-associated infections.
- TGC significantly increased the incidence of hypoglycemia (OR 6.37, 95% CI 4.41-9.21, P < 0.001).
Conclusions:
- Tight glycemic control (TGC) offers no significant benefit in reducing mortality or acquired infections in critically ill children.
- A notable increase in hypoglycemia incidence was observed in the TGC group.
- Methodological heterogeneity across trials necessitates cautious interpretation of these findings.
Background:
There still are controversies in the impact of tight glycemic control (TGC) in critically ill children. The aim of this study was to assess the benefits and risks of TGC compared with conventional glycemic control (CGC) in critically ill pediatric patients admitted to the pediatric intensive care unit (PICU) by using data retrieved from randomized controlled trials (RCTs).
Method:
EMBASE, CNKI, PubMed, and the Cochrane Database were searched for RCTs comparing TGC with CGC in critically ill children in PICU.
Result:
The meta-analysis included five RCTs representing 3933 patients and compared TGC with CGC. Our result revealed that TGC did not reduce the 30-day mortality rates (OR 0.99, 95% CI 0.74-1.32, P = 0.95) and was not associated with decreasing health care-associated infections (OR 0.80, 95% CI 0.64-1.00, P = 0.05) compared with CGC, but significantly increased the incidence of hypoglycemia (OR 6.37, 95% CI 4.41-9.21, P < 0.001).
Conclusion:
Tight glycemic control was not associated with reducing the 30-day mortality rates and acquired infections compared with CGC in critically ill children. Significant increase of the incidence of hypoglycemia was revealed in TGC group. The conclusion should be interpreted with caution for the methodological heterogeneity among trials.
Related Concept Videos
Random and Systematic Errors
Control System Problem
When forming a closed-loop system, issues can arise if the poles cross into the unstable region, leading to potential...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Control Systems
At the heart...

